According to a new major trial that could change the way millions of HIV patients are treated, drugs to treat HIV should begin at the moment of diagnosis.
Scientists at the University of North Carolina at Chapel Hill and GlaxoSmithKline are homing in on a breakthrough in the fight against AIDS-one that has remained out of reach: finding a cure. This partnership between the private company and the public university will marry the longstanding work of each entity to hopefully arrive at more than has seemed possible in even the recent past.
In the age of the slow death of the print industry, book authors and magazines must become a bit more avant garde and push their boundaries if they expect to survive. But with a bit of blood and creative marketing one German magazine may keep its face in the headlines, and its reader’s aware in the process.
When a person is infected with HIV, a battle begins to rage between the virus and the immune system. As the body produces new antibodies for the virus, the infection mutates always managing to stay a few steps ahead. Now, a team of scientists at Rockefeller University in New York believe that using synthetic antibodies that attach to the surface of proteins on the outer membrane of the virus offer an alternative treatment to anti-retroviral drugs currently used and could one day lead to new therapeutic vaccines.
Though advances in HIV research and treatment have come to find ways of mitigating the virus, the disease continues to affects millions worldwide. And when the virus moves quickly, so does fear. In light of the discovery of a new strain of HIV, many are left wondering—could you too be at risk for contracting the disease?
In a new study published in the journal EBioMedicine, researchers with Belgium’s University of Leuvan report the discovery of a new strain of HIV which may prove to be far more lethal to patients in the West. Originally found in patients in Cuba, the new strain poses particular threats to those infected with HIV as it can develop into AIDS within three years of infection. Though efforts have significantly lowered the infection rates of HIV, as well as prolonged lives with the help of antiretroviral drugs, researchers fear that the fast-moving virus may advance too quickly to treat.
Several studies have discovered that HIV vaccines can backfire and lead to increased rates of the infection, as opposed to reducing or eliminating the viral pathogen. Now, a new study published in the Proceedings of the National Academy of Sciences might have an explanation as to why this occurs.
A new study has shown that adults suffering from HIV often experience hearing loss in the upper and lower frequency ranges after years of treatments with power antiretroviral medications.
While the number of HIV-infected people have gone down over the years, and massive information campaigns have been carried out all over the world to curb the spread of the cure-less disease, figures have shown that HIV-AIDs are more prevalent in mentally-ill people.
The celebration of World AIDS Day today brings with it news of triumph against a deadly disease which, up to now, has had no known cure. More people have gained awareness on HIV, and this is due to the years of advocacy and information campaign against the spread of the disease worldwide.